Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-074388
Filing Date
2025-08-05
Accepted
2025-08-05 20:21:38
Documents
2
Period of Report
2025-08-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2522566-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2522566-5_4seq1.xml 4 9588
2 EXHIBIT 24 tm2522566d5_ex24.htm EX-24 8770
  Complete submission text file 0001104659-25-074388.txt   19797
Mailing Address C/O CURAGEN CORP 555 LONG WHARF DR. 11TH FL. NEW HAVEN CT 06511
Business Address
EBSWORTH DAVID R (Reporting) CIK: 0001207107 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38067 | Film No.: 251186894

Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Issuer) CIK: 0001657312 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)